KR20010040939A - β-시트 미메틱 및 이의 사용과 관련된 방법 - Google Patents

β-시트 미메틱 및 이의 사용과 관련된 방법 Download PDF

Info

Publication number
KR20010040939A
KR20010040939A KR1020007008856A KR20007008856A KR20010040939A KR 20010040939 A KR20010040939 A KR 20010040939A KR 1020007008856 A KR1020007008856 A KR 1020007008856A KR 20007008856 A KR20007008856 A KR 20007008856A KR 20010040939 A KR20010040939 A KR 20010040939A
Authority
KR
South Korea
Prior art keywords
compound
mmol
formula
solution
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020007008856A
Other languages
English (en)
Korean (ko)
Inventor
콰버마허엔
맥밀리안마이클케이
칸마이클에스
툴린스키존이
매튜제씨몰
Original Assignee
몰레큐메틱스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 몰레큐메틱스 리미티드 filed Critical 몰레큐메틱스 리미티드
Publication of KR20010040939A publication Critical patent/KR20010040939A/ko
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
KR1020007008856A 1998-02-12 1998-02-12 β-시트 미메틱 및 이의 사용과 관련된 방법 Ceased KR20010040939A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/002891 WO1999041276A1 (en) 1998-02-12 1998-02-12 β-SHEET MIMETICS AND METHODS RELATING TO THE USE THEREOF

Publications (1)

Publication Number Publication Date
KR20010040939A true KR20010040939A (ko) 2001-05-15

Family

ID=22266392

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007008856A Ceased KR20010040939A (ko) 1998-02-12 1998-02-12 β-시트 미메틱 및 이의 사용과 관련된 방법

Country Status (9)

Country Link
EP (1) EP1053246B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002503674A (cg-RX-API-DMAC7.html)
KR (1) KR20010040939A (cg-RX-API-DMAC7.html)
AT (1) ATE230414T1 (cg-RX-API-DMAC7.html)
AU (1) AU748887B2 (cg-RX-API-DMAC7.html)
CA (1) CA2319766A1 (cg-RX-API-DMAC7.html)
DE (1) DE69810513T2 (cg-RX-API-DMAC7.html)
ES (1) ES2192764T3 (cg-RX-API-DMAC7.html)
WO (1) WO1999041276A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003525294A (ja) * 2000-02-29 2003-08-26 ブリストル−マイヤーズ スクイブ ファーマ カンパニー C型肝炎ウイルスns3プロテアーゼの阻害剤
US6534651B2 (en) 2000-04-06 2003-03-18 Inotek Pharmaceuticals Corp. 7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
US20060276497A1 (en) 2000-05-09 2006-12-07 Cephalon, Inc. Novel multicyclic compounds and the use thereof
US7122679B2 (en) 2000-05-09 2006-10-17 Cephalon, Inc. Multicyclic compounds and the use thereof
CN1642550A (zh) * 2002-02-14 2005-07-20 美瑞德生物工程公司 β-折叠模拟物和组合物及其有关方法
JP2011525927A (ja) * 2008-06-25 2011-09-29 シェーリング コーポレイション 複素環式抗菌剤の合成および使用
BR112017006920A8 (pt) 2014-10-06 2023-03-07 Quince Therapeutics Inc Inibidores de lisina gingipaína
EP3374352A4 (en) 2015-11-09 2019-10-02 Cortexyme, Inc. GINGIPAINE ARGININE INHIBITORS
PL3486242T3 (pl) 2016-08-31 2022-03-21 Jiangsu Hengrui Medicine Co. Ltd. Pochodna oksopikolinamidu, sposób jej wytwarzania i zastosowanie farmaceutyczne
MX2019003087A (es) 2016-09-16 2019-08-12 Cortexyme Inc Inhibidores cetónicos de gingipain de lisina.
EP3822264A4 (en) 2018-07-02 2021-11-10 Jiangsu Hengrui Medicine Co., Ltd. CRYSTALLINE FORMS OF AN OXYPYRIDINE AMIDE DERIVATIVE AND THEIR PREPARATION PROCESS
WO2021057818A1 (zh) 2019-09-27 2021-04-01 深圳信立泰药业股份有限公司 FXIa抑制剂及其制备方法和医药用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2117123T3 (es) * 1992-02-14 1998-08-01 Merrell Pharma Inc Derivados de aminocetilmercaptoacetilamida utilizados como inhibidores de la encefalinasa y del enzima de conversion de angiotensina.
ES2138622T3 (es) * 1992-05-15 2000-01-16 Merrell Pharma Inc Derivados de mercaptoacetilamido piridazo(1,2-a)(1,2)diazepina utilizados como inhibidores de encefalinasa y eca.
EP0618223A3 (en) * 1993-03-08 1996-06-12 Sandoz Ltd Peptides, the release of Interleukin 1-Bêta, useful as anti-inflammatory agents.
SK83897A3 (en) * 1994-12-22 1998-05-06 Iaf Biochem Int Low molecular weight bicyclic thrombin inhibitors
EP0815123B1 (en) * 1995-03-24 2001-10-04 Molecumetics, Ltd. Beta-sheet mimetics and use thereof as protease inhibitors
WO1996030396A1 (en) * 1995-03-24 1996-10-03 Molecumetics Ltd. β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS
US5877313A (en) * 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
IT1277405B1 (it) * 1995-08-01 1997-11-10 Menarini Farma Ind Derivati di lattami biciclici come inibitori della trombina
WO1998005333A1 (en) * 1996-08-05 1998-02-12 Molecumetics Ltd. Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors

Also Published As

Publication number Publication date
EP1053246A1 (en) 2000-11-22
DE69810513T2 (de) 2004-03-18
AU6655798A (en) 1999-08-30
JP2002503674A (ja) 2002-02-05
CA2319766A1 (en) 1999-08-19
ATE230414T1 (de) 2003-01-15
EP1053246B1 (en) 2003-01-02
DE69810513D1 (de) 2003-02-06
WO1999041276A1 (en) 1999-08-19
AU748887B2 (en) 2002-06-13
ES2192764T3 (es) 2003-10-16

Similar Documents

Publication Publication Date Title
EP0915700B1 (en) Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
AU712581B2 (en) Beta-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
US6372744B1 (en) β-sheet mimetics and methods relating to the use thereof
US6245764B1 (en) β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
WO1996030396A1 (en) β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS
EP1053246B1 (en) Beta-sheet mimetics and methods relating to the use thereof
US6020331A (en) β-sheet mimetics and use thereof as protease inhibitors
US6699869B1 (en) β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
US20030191109A1 (en) Beta-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
EP1661566A2 (en) Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
AU733205B2 (en) Beta-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
AU5421301A (en) Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20000811

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20030211

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20041129

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20050302

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20041129

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I